EXECUTIVE ENGAGEMENTS
OUTREACH
1623
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
293
Interactions with Platform & by Email
PARTICIPANTS
63
Unique # Participated
VALIDATIONS
28
Responses Validated*
COMPETITORS
46
Responses Validated*
BRANDS
0
Responses Validated*
* Login for a full stack data experience
DATE
SEP 2020
TABLES
171
PAGES
247
EDITION
8
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027.Acute Diarrhea, one of the segments analyzed in the report, is projected to grow at a 14.9% CAGR to reach US$527 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Obesity segment is readjusted to a revised 12.6% CAGR for the next 7-year period. This segment currently accounts for a 4.7% share of the global Human Microbiome market.
The Human Microbiome market in the U.S. is estimated at US$115.6 Million in the year 2020. The country currently accounts for a 29.56% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$167.2 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while Rest of European market (as defined in the study) will reach US$167.2 Million by the year 2027.
In the global Diabetes segment, USA, Canada, Japan, China and Europe will drive the 13.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12 Million in the year 2020 will reach a projected size of US$29.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$114.2 Million by the year 2027.We bring years of research experience to this 8th edition of our report. The 247-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
DowDuPont, Inc.; Enterome SA; Merck & Co., Inc.; Metabiomics Corporation; Microbiome Therapeutics, LLC.; Osel, Inc.; Second Genome; Vedanta Biosciences, Inc.; ViThera Pharmaceuticals, Inc.; Yakult Honsha Co., Ltd.
SEGMENTS
» Application (Therapeutics, Diagnostics) » Disease Indication (Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases) » Product Type (Probiotics, Prebiotics, Foods, Medical Foods, Drugs, Other Product Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of Covid-19 and a Looming Global Recession |
Global Competitor Market Shares |
Human Microbiome Competitor Market Share Scenario Worldwide (in %): 2018E |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Acute Diarrhea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Medical Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
III. MARKET ANALYSIS |
GEOGRAPHIC MARKET ANALYSIS |
United States |
Market Facts & Figures |
US Human Microbiome Market Share (in %) by Company: 2018 & 2027 |
USA Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
USA Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
USA 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
USA Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
USA Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
USA 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
USA Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
USA Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
USA 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Canada |
Canada Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Canada Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Canada 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Canada Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Canada Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Canada 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Canada Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Canada Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Canada 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Japan |
Japan Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Japan Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Japan 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Japan Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Japan Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Japan 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Japan Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Japan Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Japan 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
China |
China Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
China Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
China 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
China Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
China Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
China 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
China Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
China Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
China 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Europe |
Market Facts & Figures |
European Human Microbiome Market: Competitor Market Share Scenario (in %) for 2018 & 2027 |
Europe Current & Future Analysis for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 |
Europe Historic Review for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Europe 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
France |
France Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
France Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
France 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
France Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
France Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
France 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
France Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
France Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
France 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Germany |
Germany Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Germany Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Germany 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Germany Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Germany Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Germany 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Germany Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Germany Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Germany 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Italy |
Italy Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Italy Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Italy 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Italy Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Italy Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Italy 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Italy Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Italy Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Italy 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
United Kingdom |
UK Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
UK Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
UK 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
UK Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
UK Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
UK 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
UK Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
UK Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
UK 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Rest of Europe |
Rest of Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Rest of Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Rest of Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Asia-Pacific |
Asia-Pacific Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Asia-Pacific Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Asia-Pacific 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Asia-Pacific Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Asia-Pacific Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Asia-Pacific 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Asia-Pacific Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Asia-Pacific Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Asia-Pacific 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
Rest of World |
Rest of World Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of World Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of World 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027 |
Rest of World Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of World Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of World 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027 |
Rest of World Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 |
Rest of World Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 |
Rest of World 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 46 |